Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madeline R Luth

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Cell|October 16, 2020
SnapShot: Antimalarial DrugsMadeline R Luth, Elizabeth A Winzeler
ACS Infectious Diseases|February 17, 2018
Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug DiscoveryMadeline R Luth, Purva Gupta, Sabine Ottilie, et al.
Food Microbiology|November 28, 2016
Efficacy of post-harvest rinsing and bleach disinfection of E. coli O157:H7 on spinach leaf surfacesNichola M Kinsinger, Holly M Mayton, Madeline R Luth, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2019
Evolution of resistance in vitro reveals mechanisms of artemisinin activity in <i>Toxoplasma gondii</i>Alex Rosenberg, Madeline R Luth, Elizabeth A Winzeler, et al.
Plos Neglected Tropical Diseases|December 29, 2017
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)Anjan Debnath, Claudia M Calvet, Gareth Jennings, et al.
Plos Pathogens|June 7, 2019
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agentsBarbara H Stokes, Euna Yoo, James M Murithi, et al.
Elife|September 22, 2023
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistanceRebecca E K Mandt, Madeline R Luth, Mark A Tye, et al.
Science Translational Medicine|December 6, 2019
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection modelRebecca E K Mandt, Maria Jose Lafuente-Monasterio, Tomoyo Sakata-Kato, et al.
ACS Infectious Diseases|March 15, 2021
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>Frances Rocamora, Purva Gupta, Eva S Istvan, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Mechanistic Insights into Dual-Active Liver and Blood-Stage AntiplasmodialsMukul Rawat, Nonlawat Boonyalai, Cindy Smidt, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Cell|October 16, 2020
SnapShot: Antimalarial DrugsMadeline R Luth, Elizabeth A Winzeler
ACS Infectious Diseases|February 17, 2018
Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug DiscoveryMadeline R Luth, Purva Gupta, Sabine Ottilie, et al.
Food Microbiology|November 28, 2016
Efficacy of post-harvest rinsing and bleach disinfection of E. coli O157:H7 on spinach leaf surfacesNichola M Kinsinger, Holly M Mayton, Madeline R Luth, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 7, 2019
Evolution of resistance in vitro reveals mechanisms of artemisinin activity in <i>Toxoplasma gondii</i>Alex Rosenberg, Madeline R Luth, Elizabeth A Winzeler, et al.
Plos Neglected Tropical Diseases|December 29, 2017
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)Anjan Debnath, Claudia M Calvet, Gareth Jennings, et al.
Plos Pathogens|June 7, 2019
Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agentsBarbara H Stokes, Euna Yoo, James M Murithi, et al.
Elife|September 22, 2023
Diverse evolutionary pathways challenge the use of collateral sensitivity as a strategy to suppress resistanceRebecca E K Mandt, Madeline R Luth, Mark A Tye, et al.
Science Translational Medicine|December 6, 2019
In vitro selection predicts malaria parasite resistance to dihydroorotate dehydrogenase inhibitors in a mouse infection modelRebecca E K Mandt, Maria Jose Lafuente-Monasterio, Tomoyo Sakata-Kato, et al.
ACS Infectious Diseases|March 15, 2021
PfMFR3: A Multidrug-Resistant Modulator in <i>Plasmodium falciparum</i>Frances Rocamora, Purva Gupta, Eva S Istvan, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Mechanistic Insights into Dual-Active Liver and Blood-Stage AntiplasmodialsMukul Rawat, Nonlawat Boonyalai, Cindy Smidt, et al.
Pageof 3